How does Fintiv discretionary denial affect my district court case?

Fintiv concerns discretionary institution at the Patent Office. For a patent owner, the parallel litigation schedule, overlapping issues, and applicable USPTO guidance can inform a request for discretionary denial. Any request to pause an existing infringement lawsuit is separately addressed to the district court.

Who decides institution now?

The October 17, 2025 USPTO memorandum, effective October 20, assigns institution decisions to the Director after consultation with at least three PTAB judges. It supersedes the earlier routine referral of merits institution decisions to a Board panel while retaining separate discretionary briefing. A three-member panel conducts an instituted trial.

How do I put Fintiv and related factors in front of the Director?

The USPTO's Interim Director Discretionary Process, sections II.B and III.B, sets the ordinary deadlines from the Notice of Filing Date Accorded: two months for the patent owner's discretionary-denial brief and three months for the petitioner's opposition. The opposition deadline does not run from the date the patent owner files its brief. Identify the actual parallel-case schedule, overlapping issues, and other relevant circumstances, and check the proceeding's orders and current Office guidance before filing.

Why should plaintiffs care about Fintiv-style factors?

The parallel proceeding matters because the Director may consider whether a second proceeding would duplicate work or serve an efficient resolution. The March 26, 2025 memorandum also lists prior adjudications, the strength of the challenge, and settled expectations among the relevant considerations. Explain the facts supporting the requested result rather than relying on the label Fintiv.

What changes in the district case if institution is denied or granted?

Denial means that petition does not proceed to an IPR trial. Institution opens an Office trial; it does not automatically pause an existing infringement lawsuit. The district court separately decides a requested stay, applying its case-management discretion. Neither institution outcome determines infringement or damages.

Is the Fintiv factor list static?

The March 11, 2026 memorandum adds considerations concerning U.S. manufacturing and small-business use of AIA proceedings. Read the dated memoranda together and check later Office guidance before preparing a filing. The Fintiv guide links the factor framework and supporting documents.

Where should I read next?

Start with the Fintiv breakout for the factor list and Director-institution timeline. Then see the defendant-filed-IPR FAQ, the stay-pending-PTAB FAQ, and Should I challenge the patent at the PTAB? for the accused-side mirror of the same calendar.